Effectiveness of Pharmacist Interventions in Difficult Asthma
Launched by THE LEEDS TEACHING HOSPITALS NHS TRUST · Feb 12, 2015
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of asthma
- • Fulfil the criteria for difficult asthma (defined as persistent symptoms and/or frequent exacerbations despite treatment at step 4 or step 5 of the British TYhoracic Society / SIGN asthma guidelines 2011)
- • Adult patients age between 18 and 70 years
- • Able to speak, read and write in English
- • All patients must have received their regular medication from the same Community Pharmacy for at least 3 months prior to their baseline visit
- • Their community pharmacy must be registered with Leeds Primary Care Trust(PCT) to undertake targeted Medicines Use Reviews (tMURs).
- Exclusion Criteria:
- • Failure to meet the inclusion criteria
- • Patient is not responsible for administering their own medications
- • Patient is unlikely to be available for the 6-month follow-up period
- • Failure to provide written informed consent
- • Patient has had an MUR within the 12 months preceding the study period.
About The Leeds Teaching Hospitals Nhs Trust
The Leeds Teaching Hospitals NHS Trust is a prominent healthcare organization in the United Kingdom, renowned for its commitment to delivering high-quality patient care, innovative research, and advanced medical education. As a leading clinical trial sponsor, the Trust plays a pivotal role in facilitating cutting-edge research initiatives that aim to improve health outcomes and advance medical knowledge. With a multidisciplinary team of experts and access to state-of-the-art facilities, the Trust is dedicated to fostering collaboration and ensuring the highest ethical standards in clinical research, ultimately contributing to the development of new treatments and therapies for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials